Skip to content
ChemifyLet’s talk

CASE STUDY / TUBERCULOSIS DISCOVERY

From first hits. To the next stage.

Chemify and Lgenia advanced one tuberculosis programme to hit-to-lead entry and improved potency in a second, connecting computational design, synthesis and partner-led assays with support from the Gates Foundation.

CHEMIFY / CASE STUDYEXPLORE WHAT’S POSSIBLE
THE PARTNERSHIP

Chemify × Lgenia

THE FOCUS

Two priority tuberculosis targets

SUPPORTED BY

Gates Foundation

01THE BRIEF

Keep the activity.
Improve the chemistry.

Match the activity of known inhibitors while improving drug-like properties.

That brief guided exploration across multiple chemical series and two priority tuberculosis targets. Molecular design considered biological activity, medicinal chemistry properties and the practicality of synthesis together.

02 / THE EXPERIMENTS

Design. Make.
Measure the response.

Computational design and physical compounds connected through partner-led assays.

CHEMIFY

Design, optimise and synthesise.

Chemify designed potential hits, explored chemical series and synthesised compounds for experimental evaluation.

LGENIA

Target expertise and assay testing.

Lgenia supplied structural and background information on the targets and led compound testing in the relevant project-specific assays.

03 / THE RESULTS

A development starting point.
A more potent series.

Two target programmes. Distinct advances in each.

TARGET 1

>250

Compounds synthesised

5% met the programme-defined potency goals.

The programme progressed from hit identification to the entry point for hit-to-lead development.

TARGET 2

~100

Compounds synthesised

Several-fold improvement in potency within one chemical series.

The result identified an improved series to inform further optimisation.

04WHAT THE PROGRAMME CREATED

Physical compounds.
A direction for discovery.

The value is in the compounds and the evidence they create.

For Target 1, the programme reached the entry point for hit-to-lead development. For Target 2, the potency improvement provides a basis for deciding which chemistry to optimise next.

Together, the synthesis work and Lgenia’s assay findings help the teams decide which compounds to pursue, which series to refine and what the next experiment needs to resolve.

Shape your discovery programme
Earlier published example · Mtb NadE

From virtual candidates
to physical compounds.

This earlier published case study focused on Mtb NadE. Known inhibitors had solubility and permeability limitations. Chemify synthesised 12 reference compounds and designed 28 analogues in the first cycle, using structural and pharmacophore modelling to inform the next search.

  1. EXPLORE786M+

    Virtual candidates

    Generated computationally for further filtering.

  2. PRIORITISE~50K

    After filtering

    Remaining candidates then ranked in three dimensions.

  3. MAKE70

    Compounds synthesised

    Across 14 core scaffolds in cycles two and three.

Chemify reported improved solubility and permeability relative to the starting series.

The two-target programme update is presented separately from the earlier published Mtb NadE example.

Explore ways we work

Chemify Genesis

×
Chemify film still

The Genesis vision.